Decoding ARF4 and EIF5B-Based Prognostic Signatures and Immune Landscape Following Insufficient Radiofrequency Ablation in Hepatocellular Carcinoma: Through Multi-Omics and Experimental Validation
Yixin Zhang,
No information about this author
Yongpan Lu,
No information about this author
S. Zheng
No information about this author
et al.
Journal of Hepatocellular Carcinoma,
Journal Year:
2025,
Volume and Issue:
Volume 12, P. 909 - 931
Published: May 1, 2025
Radiofrequency
ablation
(RFA)
is
pivotal
in
non-surgical
hepatocellular
carcinoma
(HCC)
treatments
but
poses
a
high
postoperative
recurrence
risk,
exceeding
conventional
surgeries.
Insufficient
tumor
may
trigger
immune
responses,
promoting
progression
locally.
Hence,
this
study
seeks
to
pinpoint
biomarkers
improve
treatment
precision
and
prognostic
accuracy
for
RFA
patients.
The
utilized
data
from
Cancer
Genome
Atlas
(TCGA),
Gene
Expression
Omnibus
(GEO),
International
Consortium
(ICGC)
database
investigate
novel
influencing
the
prognosis
of
patients
undergoing
insufficient
radiofrequency
(IRFA).
Subsequently,
an
IRFA
model
was
developed
validated.
Then,
we
employed
Quantitative
real
time-Polymerase
Chain
Reaction
(qPCR),
Western
blotting
(WB),
immunohistochemistry
(IHC),
immunofluorescence
(IF)
techniques
on
human
HCC
cell
lines
animal
validate
ADP-ribosylation
factor
4
(ARF4)
Eukaryotic
translation
initiation
5B
(EIF5B)
expression
relevance
post-IRFA.
In
addition,
knockdown
ARF4
EIF5B
performed
evaluate
proliferation,
migration,
invasion,
epithelial-mesenchymal
transition
(EMT).
Finally,
transcriptome
sequencing
subsequently
confirm
extend
our
findings.
were
identified
as
critical
targets
affecting
patient
prognosis,
forming
basis
risk
model.
High-risk
scores
correlated
with
poorer
prognoses
reduced
responsiveness
checkpoint
inhibitors
(ICIs)
across
multiple
cancer
types.
Experimental
validations
confirmed
protective
role
outcomes,
while
experiments
suggested
their
involvement
EMT
models,
potentially
through
pathways
like
P53
Transforming
Growth
Factor
Beta(TGF-β)
signaling
pathway
activation
indicated
by
sequencing.
have
demonstrated
promising
potential
following
HCC.
These
findings
suggest
they
could
serve
viable
therapeutic
aimed
at
mitigating
post-RFA.
Language: Английский
Emerging Evidence of Golgi Stress Signaling for Neuropathies
Remina Shirai,
No information about this author
Junji Yamauchi
No information about this author
Neurology International,
Journal Year:
2024,
Volume and Issue:
16(2), P. 334 - 348
Published: March 7, 2024
The
Golgi
apparatus
is
an
intracellular
organelle
that
modifies
cargo,
which
transported
extracellularly
through
the
nucleus,
endoplasmic
reticulum,
and
plasma
membrane
in
order.
First,
general
function
of
reviewed
and,
then,
stress
signaling
discussed.
In
addition
to
six
main
pathways,
two
pathways
have
been
increasingly
reported
recent
years
are
described
this
review.
focus
then
shifts
neurological
disorders,
examining
major
such
as
Alzheimer’s
disease,
Parkinson’s
Huntington’s
disease.
review
also
encompasses
findings
related
other
diseases,
including
hypomyelinating
leukodystrophy,
frontotemporal
spectrum
disorder/amyotrophic
lateral
sclerosis,
microcephaly,
Wilson’s
prion
Most
these
disorders
cause
fragmentation
stress.
As
a
result,
strong
signals
may
act
induce
apoptosis.
Language: Английский
ARF4-mediated retrograde trafficking as a driver of chemoresistance in GBM
Neuro-Oncology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 19, 2024
Abstract
Background
Cellular
functions
hinge
on
the
meticulous
orchestration
of
protein
transport,
both
spatially
and
temporally.
Central
to
this
process
is
retrograde
trafficking,
responsible
for
targeting
proteins
nucleus.
Despite
its
link
many
diseases,
implications
trafficking
in
glioblastoma
(GBM)
are
still
unclear.
Methods
To
identify
genetic
drivers
TMZ
resistance,
we
conducted
comprehensive
CRISPR-knockout
screening,
revealing
ADP-ribosylation
factor
4
(ARF4),
a
regulator
as
major
contributor.
Results
Suppressing
ARF4
significantly
enhanced
sensitivity
GBM
patient-derived
xenograft
(PDX)
models,
leading
improved
survival
rates
(P
<
.01)
primary
recurrent
lines.
We
also
observed
that
exposure
stimulates
ARF4-mediated
trafficking.
Proteomics
analysis
cells
with
varying
levels
unveiled
influence
pathway
EGFR
signaling,
increased
nuclear
overexpression
treatment.
Additionally,
resolved
RNA-sequencing
patient
tissues
revealed
substantial
correlations
between
crucial
(nEGFR)
downstream
targets,
such
MYC,
STAT1,
DNA-PK.
Decreased
activity
DNA-PK,
DNA
repair
nEGFR
signaling
contributes
was
suppressed
levels.
Notably,
treatment
DNA-PK
inhibitor,
KU-57788,
mice
PDX
line
resulted
prolonged
.01),
highlighting
promising
therapeutic
reliant
Conclusions
Our
findings
demonstrate
development
cementing
viable
strategy
overcome
chemoresistance
GBM.
Language: Английский
Modulating Golgi Stress Signaling Ameliorates Cell Morphological Phenotypes Induced by CHMP2B with Frontotemporal Dementia-Associated p.Asp148Tyr
Shoya Fukatsu,
No information about this author
Maho Okawa,
No information about this author
Miyu Okabe
No information about this author
et al.
Current Issues in Molecular Biology,
Journal Year:
2024,
Volume and Issue:
46(2), P. 1398 - 1412
Published: Feb. 5, 2024
Some
charged
multivesicular
body
protein
2B
(CHMP2B)
mutations
are
associated
with
autosomal-dominant
neurodegenerative
frontotemporal
dementia
and/or
amyotrophic
lateral
sclerosis
type
7
(FTDALS7).
The
main
aim
of
this
study
is
to
clarify
the
relationship
between
expression
mutated
CHMP2B
displaying
FTD
symptoms
and
defective
neuronal
differentiation.
First,
we
illustrate
that
Asp148Tyr
(D148Y)
mutation,
which
preferentially
displays
phenotypes,
blunts
neurite
process
elongation
in
rat
primary
cortical
neurons.
Similar
results
were
observed
N1E-115
cell
line,
a
model
undergoes
elongation.
Second,
these
effects
also
accompanied
by
changes
differentiation
marker
expression.
Third,
wild-type
was
indeed
localized
endosomal
sorting
complexes
required
transport
(ESCRT)-like
structures
throughout
cytoplasm.
In
contrast,
D148Y
mutation
exhibited
aggregation-like
accumulated
Golgi
body.
Fourth,
among
currently
known
stress
regulators,
levels
Hsp47,
has
protective
on
body,
decreased
cells
expressing
mutation.
Fifth,
Arf4,
another
stress-signaling
molecule,
increased
mutant-expressing
cells.
Finally,
when
transfecting
Hsp47
or
knocking
down
Arf4
small
interfering
(si)RNA,
cellular
phenotypes
recovered.
These
suggest
acting
through
signaling,
negatively
involved
regulation
morphological
differentiation,
providing
evidence
molecule
controlling
may
be
one
potential
therapeutic
targets
at
molecular
levels.
Language: Английский